Population pharmacokinetic meta-analysis and dosing recommendation for meropenem in critically ill patients receiving continuous renal replacement therapy

Y Peng, Z Cheng, F Xie - Antimicrobial Agents and Chemotherapy, 2022 - Am Soc Microbiol
The optimal dosing regimen for meropenem in critically ill patients undergoing continuous
renal replacement therapy (CRRT) remains undefined due to small studied sample sizes …

Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial

G Monti, N Bradić, M Marzaroli, A Konkayev… - Jama, 2023 - jamanetwork.com
Importance Meropenem is a widely prescribed β-lactam antibiotic. Meropenem exhibits
maximum pharmacodynamic efficacy when given by continuous infusion to deliver constant …

Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study

U Liebchen, H Salletmeier, S Kallee, C Scharf… - Scientific reports, 2021 - nature.com
The aim of this study was to investigate optimal loading doses prior to continuous infusion of
meropenem in critically ill patients. A previously published and successfully evaluated …

Continuous infusion versus intermittent administration of meropenem in critically ill patients

F Thalhammer, F Traunmüller… - Journal of …, 1999 - academic.oup.com
This prospective crossover study compared the pharmacokinetics of meropenem by
continuous infusion and by intermittent administration in critically ill patients. Fifteen patients …

Meropenem model-informed precision dosing in the treatment of critically ill patients: can we use it?

L Li, SDT Sassen, TMJ Ewoldt, A Abdulla… - Antibiotics, 2023 - mdpi.com
The number of pharmacokinetic (PK) models of meropenem is increasing. However, the
daily role of these PK models in the clinic remains unclear, especially for critically ill patients …

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial

I Chytra, M Stepan, J Benes, P Pelnar, A Zidkova… - Critical care, 2012 - Springer
Introduction Meropenem bactericidal activity depends on the time when the free drug
concentrations remain above the minimum inhibitory concentration of pathogens. The goal …

Evaluation of empirical dosing regimens for meropenem in intensive care unit patients using population pharmacokinetic modeling and target attainment analysis

G An, CB Creech, N Wu, RL Nation, K Gu… - Antimicrobial agents …, 2023 - Am Soc Microbiol
In the present study, population pharmacokinetic (PK) analysis was performed based on
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …

Optimization of meropenem dosage in the critically ill population based on renal function

JL Crandon, RE Ariano, SA Zelenitsky, AM Nicasio… - Intensive care …, 2011 - Springer
Purpose To develop a meropenem population pharmacokinetic model in critically ill patients
with particular focus on optimizing dosing regimens based on renal function. Methods …

Meropenem pharmacokinetics and target attainment in critically ill patients are not affected by extracorporeal membrane oxygenation: a matched cohort analysis

M Gijsen, E Dreesen, P Annaert, J Nicolai, Y Debaveye… - Microorganisms, 2021 - mdpi.com
Existing evidence is inconclusive whether meropenem dosing should be adjusted in
patients receiving extracorporeal membrane oxygenation (ECMO). Therefore, the aim of this …

Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study

L Ehmann, M Zoller, IK Minichmayr, C Scharf, B Maier… - Critical care, 2017 - Springer
Background Severe bacterial infections remain a major challenge in intensive care units
because of their high prevalence and mortality. Adequate antibiotic exposure has been …